Wohl & Fruchter Investigates Semler-Strive Merger Fairness Amid Fixed Exchange Ratio Concerns
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 09 2025
0mins
Source: Globenewswire
- Merger Fairness Investigation: Wohl & Fruchter LLP is investigating the proposed merger between Semler Scientific and Strive Asset Management due to concerns over the fixed exchange ratio of 21.05 shares of Strive for each Semler share, which may adversely affect shareholder interests.
- Stock Price Decline Impact: Since the merger announcement on September 22, 2025, Strive's stock price has plummeted, causing Semler's stock to drop from $32.06 to $19.77, significantly diminishing the merger's appeal and potentially leading to shareholder opposition.
- Legal Consultation Opportunity: Wohl & Fruchter LLP offers free legal consultations for Semler shareholders to discuss the fairness of the merger and their legal rights, demonstrating a commitment to protecting shareholder interests.
- Investor Rights Protection: The firm has over a decade of experience representing investors in litigation related to fraud and corporate misconduct, recovering hundreds of millions in damages, highlighting its expertise in safeguarding investor rights.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like SMLR with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on SMLR
Wall Street analysts forecast SMLR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SMLR is 51.00 USD with a low forecast of 51.00 USD and a high forecast of 51.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 20.330
Low
51.00
Averages
51.00
High
51.00
Current: 20.330
Low
51.00
Averages
51.00
High
51.00
About SMLR
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Strive, Inc. Completes Semler Scientific Acquisition, Holds 12,797.9 Bitcoin
- Bitcoin Holdings Increase: Following the acquisition of Semler Scientific, Strive now holds approximately 12,797.9 bitcoins, making it the 11th largest public corporate holder globally, thereby enhancing its market position in the digital asset space.
- Strategic Executive Appointment: Avik Roy has been appointed as Chief Strategy Officer, focusing on monetizing the Semler Scientific subsidiary's early disease detection products, which is expected to drive innovation and growth in the healthcare technology sector.
- Management Changes: Eric Semler joins Strive's board as an independent member, while Joe Burnett takes on the role of VP of Bitcoin Strategy, bringing extensive industry experience that will support the company's strategic development in both Bitcoin and medical devices.
- Asset Management Expansion: Since launching its first ETF in August 2022, Strive Asset Management has grown to manage over $2 billion in assets, and the acquisition of Semler Scientific is anticipated to further enhance its competitiveness and market share in Bitcoin asset management.
Continue Reading
Crypto Treasury Stocks, Including Strategy, Encounter a Risky Downward Trend: Ways to Overcome It.
Impact on Companies: Companies holding cryptocurrencies on their balance sheets have experienced significant losses recently.
Decline in Value: The value of their digital assets and the premium on their shares have both decreased.
Future Recovery: These companies are expected to face challenges in recovering by 2026.
Crypto-Treasury Stocks: The term 'crypto-treasury' refers to stocks of companies that have invested heavily in cryptocurrencies.
Continue Reading